Injection of a specific monoclonal anti-α5 antibody in several murine cancer models shows that α5 integrin subunitis expressed on the luminal side of the tumor vasculature and thereby directly accessible for potential anti-α5 agents [49]. This evidence concerns the gene IGKV2D-26 and cancer.